Pharvaris (PHVS) Common Equity (2019 - 2026)
Pharvaris' Common Equity was $349.65 trillion in Q2 2026, compared with $208.66 million a year earlier and up 26.4% from the prior quarter.
Powered by 
Analysis
Pharvaris (PHVS) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Pharvaris came in at $306.49 trillion.
- Common Equity shows a five-year compound annual growth rate of 1847.6% (FY2020 to FY2025).
- In earlier years, Common Equity was $289.81 million in FY2024 (-30.2%), $415.43 million in FY2023 (+164.1%), $157.31 million in FY2022 (-35.1%) and $242.54 million in FY2021 (+121.8%).
- The Q2 2026 figure marks the highest quarterly Common Equity since Q1 2024.
- Compared with a year earlier, Common Equity was higher in 1 of the last five quarters, with an average decline of 35.4%.
- The best year-over-year quarter for Common Equity over five years was Q1 2024 (growth of 181.5%); the worst was Q1 2025 (a decline of 100.0%).
- Per Business Quant data, PHVS's Common Equity in the three quarters before Q2 2026 was $276.69 trillion (Q1 2026), $315.78 trillion (Q4 2025) and $365.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Pharvaris | 2.22 Bn | 841.01 Mn | - | 343.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 343.59 Mn |
| Mar 31, 2026 | 270.84 Mn |
| Dec 31, 2025 | 318.67 Mn |
| Sep 30, 2025 | 366.30 Mn |
| Jun 30, 2025 | 216.18 Mn |
| Mar 31, 2025 | 243.90 Mn |
| Dec 31, 2024 | 278.64 Mn |
| Sep 30, 2024 | 331.51 Mn |
| Jun 30, 2024 | 356.34 Mn |
| Mar 31, 2024 | 387.70 Mn |
| Dec 31, 2023 | 425.07 Mn |
| Sep 30, 2023 | 161.74 Mn |
| Jun 30, 2023 | 188.81 Mn |
| Mar 31, 2023 | 140.83 Mn |
| Dec 31, 2022 | 159.12 Mn |
| Sep 30, 2022 | 182.02 Mn |
| Jun 30, 2022 | 199.08 Mn |
| Mar 31, 2022 | 213.07 Mn |
| Dec 31, 2021 | 232.11 Mn |
| Sep 30, 2021 | 249.93 Mn |
API Access
Pharvaris Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();